Research Report on China's Antidepressant Market, 2013-2017
Research Report on Chinas Antidepressant Market, 2013-2017Report Details:Published:December 2012No. of Pages: 50Price: Single User License – US$2800Oct. 10 is "World Mental Health Day". In 2012, its theme is "Depression: a Global Crisis".According to statistics from the United Nations, about 350 million people suffer from depression inthe world. Approximately one million people commit suicide every year because of depression.Depression becomes a health crisis worldwide.Depression (also DEP) is a set of mood disorders or affective disorders with the main symptom ofdepression caused by various reasons. It is a set of clinical syndrome or conditions centered bythe depression of mood self-experience, which is characterized by chronicity, repeated outbreakand various symptoms such as depressed mood, sorrow and pain, lack of interest and pleasantsensation and no motivation. It is generally believed that the morbidity of depression is mainlyassociated with biochemical factors such as 5-HT, DA and NE, genetic factors as well as socialand environmental factors.In developed countries, the sales volume of medicines for depression and anxiety disorderamounts to 45% of market share of nervous centralis medicines. Depressant medicines andschizophrenia drugs totally account for 80% of worlds mental disorder medicines. There are totally50 to 60 varieties of antidepressants on the market or in development, which is more thantherapeutic agents of schizophrenia. According to reports, the current eight best-sellingantidepressants globally are Fluoxetine, Paroxetine, Sertraline, Fluvoxamine, Venlafaxine,Mirtazapine, Duloxetine and Amitriptyline, and the total sales amount exceeds 80% of globalantidepressant market.With the rapid development of economy, continuous improvement in peoples living standards,continuously-intensified social competition, recombination of labor forces and changes inpopulation and family structures, depression presents an obviously increasing trend in China. It isestimated that there are over 30 million depression patients in China, among which more than90% cannot be promptly diagnosed and treated, causing deterioration of diseases and evenserious consequences of committing suicide. Statistics show that committing suicide becomes animportant cause of death among young adults aged between 15 and 34 in China. Among thesecrowds, depression patients account for about two-thirds.
At present, the market size of Chinas antidepressants is very small. In 2012, the market size ofChinas antidepressants in hospital medicines is only about CNY 3.2 billion, with an increase of22.6% YOY. In terms of national medicine market, the antidepressant market is still in a small sizeon the whole. However, with the increasing recognition rate of doctors for depression and peopleschanges in treatment concepts, it is expected that the future potential of Chinas antidepressantmarket is fairly great. It is predicted that in coming years, the annual growth rate of market size ofChinas antidepressants in hospital medicines will maintain over 20%.More following information can be acquired through this report:•Morbidity of Chinas Depression•Current Market of Chinas Antidepressants in Hospital Medicines•Competition in Chinas Antidepressant Market•Development Trends of Technologies and Market of Chinas AntidepressantsFollowing people are recommended to buy this report:•Antidepressant Manufacturers•Pharmaceutical Trade Enterprises and Hospitals•Investors and Research Institutions Focusing on Pharmaceutical IndustryGet your copy of this report @http://www.reportsnreports.com/reports/213580-research-report-on-chinas-antidepressant-market-2013-2017.htmlMajor points covered in Table of Contents of this report includeTable of Contents1 Overview on Antidepressants1.1 Current Clinical Application of Antidepressants1.2 Monoamine Oxidase Inhibitors (MAOI)1.3 Tricyclic Antidepressants (TCA)1.4 Selective 5-HT Reuptake Inhibitors (SSRI)1.4.1 Fluoxetine1.4.2 Paroxetine1.4.3 Setraline1.4.4 Fluvoxamine1.4.5 Citalopram1.4.6 Escitalopram1.5 NARI1.5.1 Maprotiline1.5.2 Reboxetine1.5.3 Mianserine1.6 SNRI1.6.1 Venlafaxine1.6.2 Trazodone1.6.3 Nefazodone
1.6.4 Mirtazapine1.6.5 Duloxetine1.7 Plant Antidepressants1.8 Others1.8.1 Tianeptine1.8.2 Deanxit1.8.3 Loripram1.8.4 S-aemesyl-methionine2 Market Conditions of Chinas Antidepressants, 2011-20122.1 Market Size of Antidepressants in Hospital Medicines2.2 Market Share of Antidepressants2.3 Market Share of Major Antidepressant Manufacturers2.4 Growth Rates of Major Antidepressant Varieties in Market3 Analysis on Major Varieties of Chinas Antidepressants, 2011-20123.1 Fluoxetine3.2 Venlafaxine3.3 Sertraline3.4 Citalopram3.5 Mirtazapine3.6 Fluvoxamine3.7 Trazodone3.8 Clomipramine3.9 Duloxetine3.10 Neurostan (Extract of St. Johns Wort)4 Reference Prices of Chinas Major Antidepressants, 20125 Prediction on Development of Chinas Antidepressants, 2013-20175.1 Prediction on Market Size5.2 Technological TrendsList Of ChartsChart Market Size of Global Antidepressants, 2007-2011Chart Market Size of Chinas Antidepressants in Hospital Medicines, 2007-2012Chart Market Shares of Chinas Major Antidepressant Varieties in Hospital Medicines, 2008-2011Chart Market Shares of Chinas Fluoxetine Enterprises in Hospital Medicines, 2010-2011Chart Market Size of Chinas Fluoxetine in Hospital Medicines, 2010-2011Chart Market Shares of Chinas Venlafaxine Enterprises in Hospital Medicines, 2010-2011Chart Market Shares of Chinas Sertraline Enterprises in Hospital Medicines, 2010-2011
Chart Market Shares of Chinas Citalopram Enterprises in Hospital Medicines, 2010-2011Chart Market Shares of Chinas Mirtazapine Enterprises in Hospital Medicines, 2010-2011Chart Prediction on Market Size of Chinas Antidepressants in Hospital Medicines, 2013-2017Contact: firstname.lastname@example.org for more information.